# Study of the Usefulness of the Probiotic 'Lactobacillus Reuteri' in the Therapy of Quadruple Eradication of Helicobacter Pylori Infection in Usual Clinical Practice.

> **NCT03150394** · PHASE4 · UNKNOWN · sponsor: **Dr. Luis Fernandez** · enrollment: 80 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DIETARY_SUPPLEMENT:** GASTRUS
- **OTHER:** PLACEBO

## Key facts

- **NCT ID:** NCT03150394
- **Lead sponsor:** Dr. Luis Fernandez
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-04
- **Primary completion:** 2018-06
- **Final completion:** 2018-08
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2017-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03150394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03150394, "Study of the Usefulness of the Probiotic 'Lactobacillus Reuteri' in the Therapy of Quadruple Eradication of Helicobacter Pylori Infection in Usual Clinical Practice.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03150394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*